Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1141-1150 of 1,396) with videos related to

Pageof 140
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|April 28, 2021
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results from the BETonMACE Randomized Controlled TrialKamyar Kalantar-Zadeh, Gregory G Schwartz, Stephen J Nicholls, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 7, 2023
Association between spontaneous internal carotid artery dissection and perivascular adipose tissue attenuation on computed tomography angiographyKevin Cheng, Andrew Lin, Ximena Stecher, et al.
American Heart Journal|April 4, 2025
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)Leslie Cho, Stephen J Nicholls, Børge G Nordestgaard, et al.
European Heart Journal|May 7, 2013
Factors underlying regression of coronary atheroma with potent statin therapyRishi Puri, Steven E Nissen, Christie M Ballantyne, et al.
Obesity Research & Clinical Practice|December 17, 2019
Epicardial and subcutaneous adipose tissue in Indigenous and non-Indigenous individuals: Implications for cardiometabolic diseasesDavid F Sun, Nadarajah Kangaharan, Benedict Costello, et al.
JACC. Cardiovascular Imaging|August 24, 2020
Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular UltrasoundNajdat Bazarbashi, Samir R Kapadia, Stephen J Nicholls, et al.
European Heart Journal. Cardiovascular Imaging|January 23, 2014
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURNRishi Puri, Peter Libby, Steven E Nissen, et al.
Heart (British Cardiac Society)|March 3, 2018
Evaluation of human coronary vasodilator function predicts future coronary atheroma progressionSamuel L Sidharta, Timothy J Baillie, Stuart Howell, et al.
JAMA Cardiology|December 23, 2025
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical TrialStephen J Nicholls, Donna H Ryan, John Deanfield, et al.
American Heart Journal|September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialA Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Pageof 140

Showing results (1141-1150 of 1,396) with videos related to

Sort By:
Pageof 140
Clinical Journal of the American Society of Nephrology : CJASN|April 28, 2021
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results from the BETonMACE Randomized Controlled TrialKamyar Kalantar-Zadeh, Gregory G Schwartz, Stephen J Nicholls, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 7, 2023
Association between spontaneous internal carotid artery dissection and perivascular adipose tissue attenuation on computed tomography angiographyKevin Cheng, Andrew Lin, Ximena Stecher, et al.
American Heart Journal|April 4, 2025
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)Leslie Cho, Stephen J Nicholls, Børge G Nordestgaard, et al.
European Heart Journal|May 7, 2013
Factors underlying regression of coronary atheroma with potent statin therapyRishi Puri, Steven E Nissen, Christie M Ballantyne, et al.
Obesity Research & Clinical Practice|December 17, 2019
Epicardial and subcutaneous adipose tissue in Indigenous and non-Indigenous individuals: Implications for cardiometabolic diseasesDavid F Sun, Nadarajah Kangaharan, Benedict Costello, et al.
JACC. Cardiovascular Imaging|August 24, 2020
Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular UltrasoundNajdat Bazarbashi, Samir R Kapadia, Stephen J Nicholls, et al.
European Heart Journal. Cardiovascular Imaging|January 23, 2014
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURNRishi Puri, Peter Libby, Steven E Nissen, et al.
Heart (British Cardiac Society)|March 3, 2018
Evaluation of human coronary vasodilator function predicts future coronary atheroma progressionSamuel L Sidharta, Timothy J Baillie, Stuart Howell, et al.
JAMA Cardiology|December 23, 2025
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical TrialStephen J Nicholls, Donna H Ryan, John Deanfield, et al.
American Heart Journal|September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialA Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Pageof 140